Evidence map›Paper›PMID 26840647›Full record

ArticleCell proliferation2016

Decellularized human amniotic membrane: how viable is it as a delivery system for human adipose tissue-derived stromal cells?

M Gholipourmalekabadi, M Sameni, Dina Radenkovic, M Mozafari, M Mossahebi-Mohammadi, A Seifalian

Open access · bronzeAbstract read
In one paragraph

Article in Cell proliferation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

M GholipourmalekabadiBiotechnology Department, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 198396-3113, Iran.
M SameniCellular and Molecular Biology Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, 198396-3113, Iran.
Dina RadenkovicUniversity College London (UCL) Medical School, London, WC1E 6BT, UK.
M MozafariBioengineering Research Group, Nanotechnology and Advanced Materials Department, MERC, Tehran, 14155-4777, Iran.
M Mossahebi-MohammadiDepartment of Hematology and Blood Banking, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, 14115-111, Iran.
A SeifalianCentre for Nanotechnology & Regenerative Medicine, UCL and Royal Free Hospital, London, NW3 2QG, UK.
Shahid Beheshti University of Medical Sciences · IRLondon Centre for Nanotechnology · GBMaterials and Energy Research Center · IRTarbiat Modares University · IRUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHuman amniotic membrane (HAM) has been widely used in soft tissue engineering both in its fresh form and decellularized; its efficiency to aid treatment of burn injuries is well known. On the other hand, it has been reported clinically by several studies that human adipose-derived stem cells (hADSC) are a promising cell source for cell therapy for burns. Recently, we have reported a new technique for decellularization of HAM. In this study, potential of prepared decellularized HAM (dHAM) as a viable support for proliferation and delivery of hADSC was investigated. MATERIALS AND

methodsAmniotic membranes were collected, decellularized and preserved according to the protocol described in our previously published study. hADSC were obtained from the patients undergoing elective liposuction surgery and cells were then seeded on the decellularized membrane for various times. Efficiency of the decellularized membrane as a delivery system for hADSC was investigated by MTT, LDH specific activity, DAPI staining and SEM.

resultsThe results showed that dHAM provided a supporting microenvironment for cell growth without producing any cytotoxic effects. In addition, the cells were spread out and actively attached to the dHAM scaffold.

conclusionThese results strongly suggest that dHAMs have considerable potential as 3D cell-carrier scaffolds for delivery of hADSC, in tissue engineering and regenerative medicine applications.

Indexed as

Tissue SurvivalAdipose TissueAmnionCell DeathCells, CulturedCell SurvivalHumansIndolesStaining and LabelingStromal CellsTissue EngineeringTissue ScaffoldsDAPIIndoles

Identifiers

PMID26840647
PMCPMC6496672
OpenAlexW2341656761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.